Literature DB >> 3263920

Functional discrimination between interleukin 6 and interleukin 1.

M Helle1, L Boeije, L A Aarden.   

Abstract

In this study we have investigated the specificity of bioassays in which interleukin (IL) 1 and/or IL 6 are active. The thymocyte assay cannot be used to discriminate between IL 1 and IL 6; both monokines are active in this assay. Moreover the detection limit for both IL 1 and IL 6 is around 100 pg/ml. IL 6 activity can be measured with a murine hybridoma cell line (B9). The detection limit for human as well as murine IL 6 is about 0.5 pg/ml. The assay is specific for IL 6 and is not influenced by a variety of other cytokines except for murine IL 4 which shows some activity in this variety of other cytokines except for murine IL 4 which shows some activity in this assay. IL 1 can be measured specifically with D10 cells. The detection limit for IL 1 alpha and IL 1 beta is around 1 pg/ml whereas IL 6 is not active in this assay at all. Upon stimulation by IL 1 and/or IL 2 D10 cells produce IL 6. However, this IL 6 does not seem to be involved in the proliferation of these cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263920     DOI: 10.1002/eji.1830181010

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  95 in total

1.  Role of interleukin-1 beta, interleukin-6, and TNF-alpha in intestinal maturation induced by dietary spermine in rats.

Authors:  M Kaouass; P Deloyer; I Gouders; O Peulen; G Dandrifosse
Journal:  Endocrine       Date:  1997-04       Impact factor: 3.633

Review 2.  Analysing the effect of novel therapies on cytokine expression in experimental arthritis.

Authors:  Richard O Williams; Julia J Inglis; Egle Simelyte; Gabriel Criado; Percy F Sumariwalla
Journal:  Int J Exp Pathol       Date:  2005-10       Impact factor: 1.925

3.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

4.  Immunopathological features of rat Staphylococcus aureus arthritis.

Authors:  T Bremell; S Lange; R Holmdahl; C Rydén; G K Hansson; A Tarkowski
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity.

Authors:  R Madhok; A Crilly; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

6.  Acute sterile inflammation--correlation between cellular changes and extramedullary-produced regulators in vivo.

Authors:  G Jovcić; N Stojanović; M Kataranovski; M Petakov; P Obradović
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

7.  The retinoic acid analog CBS-211A potentiates the 1 alpha,25-dihydroxyvitamin D3-induced differentiation of U937 cells.

Authors:  M Taimi; H Defacque; T Commes; J Favero; J Dornand; J Marti
Journal:  Agents Actions       Date:  1993-01

8.  Isotype-specific cross-linking of select human Fc gamma R isoforms triggers release of IL-6.

Authors:  A J Duits; L A Aarden; L K Ernst; P J Capel; J G van de Winkel
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  Sigma factor B and RsbU are required for virulence in Staphylococcus aureus-induced arthritis and sepsis.

Authors:  Ing-Marie Jonsson; Staffan Arvidson; Simon Foster; Andrzej Tarkowski
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer.

Authors:  E C De Boer; W H De Jong; P A Steerenberg; L A Aarden; E Tetteroo; E R De Groot; A P Van der Meijden; P D Vegt; F M Debruyne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.